65,437 trials
Acute Non-cardioembolic Ischemic Stroke
Primary: Efficacy-Number of Participants With Composite of Symptomatic Ischemic Stroke or Covert Brain Infarcts Detected by Magnetic Resonance Imaging (MRI) — 24; 25; 17; 23…
Estrogen Receptor Negative · Estrogen Receptor Positive · HER2/Neu Negative
Primary: Number of Participants With Overall Response — 5; 2 Participants
Inflammation and Pain Following Ocular Surgery
Primary: Absence of Anterior Chamber Cells at Day 15 (Visit 5) — 10; 12; 11; 27 Participants — p=0.4543
B-Cell Chronic Lymphocytic Leukemia · B-Lymphocytic Leukemia, Chronic · Chronic Lymphocytic Leukemia
Primary: Number of Participants With Complete Response of the Combination of Ibrutinib, Fludarabine, and Pembrolizumab in Patients With High-risk and/or Relapsed/Refractory…
Diarrhea · Metastatic Renal Cell Carcinoma · Stage IV Renal Cell Cancer
Primary: Number of Participants With Overall Response — 2; 1 Participants
Malaria
Primary: Number of Participants Reporting Local Reactogenicity Signs and Symptoms Within 7 Days of CIS43LS Product Administration — 4; 1; 5; 3 Participants
Endometrial Cancer
Primary: Progression Free Survival Differences Between Treatment Arms. — 8.049; 12.945 months
Angelman Syndrome
Primary: Bayley Scales of Infant and Toddler Development, 2nd Edition (BSID-II) Score at Baseline, 8 Weeks After Treatment, and at 16 Week Follow-up — 26.4; 31.7; 30.7; 18.9…
Diabetes · Gastroparesis With Diabetes Mellitus
Primary: Uptake of 11C-ER 176 in the Stomach Muscle — 5.5; 8.4; 4.6; 7.8 SUVmax
Anesthesia
Primary: End-tidal Sevoflurane Concentration — 2.1; 1.8; 2.5; 2.1 percent sevoflurane
Meningococcal Vaccine
Primary: Percentage of Participants Achieving At Least 4-Fold Rise in Serum Bactericidal Assay Using Human Complement (hSBA) Titer From Baseline for Each MenACWY Strains: 1 Month…
Type 2 Diabetes · Homeless Persons
Primary: Acceptability of Intervention — 25.4 score on a scale
Asthma in Children · Humans · Hispanic Americans
Primary: Change in Percentage of Doses Received — 22.0; 12.4 Percentage of doses received
Chronic Pain
Primary: Needle Placement Pain Score — 0; 0 units on a scale
Refractive Errors
Primary: Least Squares Mean Distance Visual Acuity (VA) With Study Lenses — -0.13; -0.13 logMAR